ExploreWatchlistsPricing
  1. JP-listed companies
  2. Sumitomo Pharma Co., Ltd.
  3. Financials
  4. Total current liabilities

Sumitomo Pharma Co., Ltd. (4506)

Market cap
¥877B
P/E ratio
9.5x
Sumitomo Pharma manufactures and sells prescription pharmaceuticals globally, with specialized focus on regenerative and cell medicine through joint ventures.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndTotal current liabilities (Million JPY)YoY (%)
Mar 31, 2025240,603-53.32%
Mar 31, 2024515,474+38.31%
Mar 31, 2023372,694+33.88%
Mar 31, 2022278,373+0.08%
Mar 31, 2021278,147-43.98%
Mar 31, 2020496,498+150.54%
Mar 31, 2019198,174+188.21%
Mar 31, 201868,761-69.90%
Mar 31, 2017228,447+27.11%
Mar 31, 2016179,722+14.59%
Mar 31, 2015156,843

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat